CHEK2:1100delC and female breast cancer in the United States

被引：16

作者：

Pereira, LHM

Sigurdson, AJ

Doody, MM

Pineda, MA

Alexander, BH

Greene, MH

Struewing, JP

机构：

[1] NCI, Lab Populat Genet, Bethesda, MD 20892 USA

[2] NCI, Radiat Epidemiol Branch, Bethesda, MD 20892 USA

[3] Univ Minnesota, Div Environm & Occupat Hlth, Minneapolis, MN 55455 USA

[4] NCI, Clin Genet Branch, Bethesda, MD 20892 USA

来源：

INTERNATIONAL JOURNAL OF CANCER | 2004年 / 112卷 / 03期

关键词：

D O I：

10.1002/ijc.20439

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：541 / 543

页数：3

共 15 条

[1] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].

Bell, DW ;

Varley, JM ;

Szydlo, TE ;

Kang, DH ;

Wahrer, DCR ;

Shannon, KE ;

Lubratovich, M ;

Verselis, SJ ;

Isselbacher, KJ ;

Fraumeni, JF ;

Birch, JM ;

Li, FP ;

Garber, JE ;

Haber, DA .

SCIENCE, 1999, 286 (5449) :2528-2531

[2] Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].

Meijers-Heijboer, H ;

van den Ouweland, A ;

Klijn, J ;

Wasielewski, M ;

de Snoo, A ;

Oldenburg, R ;

Hollestelle, A ;

Houben, M ;

Crepin, E ;

van Veghel-Plandsoen, M ;

Elstrodt, F ;

van Duijn, C ;

Bartels, C ;

Meijers, C ;

Schutte, M ;

McGuffog, L ;

Thompson, D ;

Easton, DF ;

Sodha, N ;

Seal, S ;

Barfoot, R ;

Mangion, J ;

Chang-Claude, J ;

Eccles, D ;

Eeles, R ;

Evans, DG ;

Houlston, R ;

Murday, V ;

Narod, S ;

Peretz, T ;

Peto, J ;

Phelan, C ;

Zhang, HX ;

Szabo, C ;

Devilee, P ;

Goldgar, D ;

Futreal, PA ;

Nathanson, KL ;

Weber, BL ;

Rahman, N ;

Stratton, MR .

NATURE GENETICS, 2002, 31 (01) :55-59

[3] The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype [J].

Meijers-Heijboer, H ;

Wijnen, J ;

Vasen, H ;

Wasielewski, M ;

Wagner, A ;

Hollestelle, A ;

Elstrodt, F ;

van den Bos, R ;

de Snoo, A ;

Fat, GTA ;

Brekelmans, C ;

Jagmohan, S ;

Franken, P ;

Verkuijlen, P ;

van den Ouweland, A ;

Chapman, P ;

Tops, C ;

Möslein, G ;

Burn, J ;

Lynch, H ;

Klijn, J ;

Fodde, R ;

Schutte, M .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1308-1314

[4]

Mohan AK, 2002, J NATL CANCER I, V94, P943, DOI 10.1093/jnci/94.12.943

[5] Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers [J].

Neuhausen, S ;

Dunning, A ;

Steele, L ;

Yakumo, K ;

Hoffman, M ;

Szabo, C ;

Tee, L ;

Baines, C ;

Pharoah, P ;

Goldgar, D ;

Easton, D .

INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (03) :477-478

[6]

Offit Kenneth, 2003, BMC Med Genet, V4, P1, DOI 10.1186/1471-2350-4-1

[7] CHEK2*1100delC and male breast cancer risk in Israel [J].

Ohayon, T ;

Gal, I ;

Baruch, RG ;

Szabo, C ;

Friedman, E .

INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (03) :479-480

[8]

Oldenburg RA, 2003, CANCER RES, V63, P8153

[9] The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population [J].

Osorio, A ;

Rodríguez-López, R ;

Díez, O ;

de la Hoya, M ;

Martínez, JI ;

Vega, A ;

Esteban-Cardeñosa, E ;

Alonso, C ;

Caldés, T ;

Benítez, J .

INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) :54-56

[10] Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals [J].

Rutter, JL ;

Smith, AM ;

Dávila, MR ;

Sigurdson, AJ ;

Giusti, RM ;

Pineda, MA ;

Doody, MM ;

Tucker, MA ;

Greene, MH ;

Zhang, JH ;

Struewing, JP .

HUMAN MUTATION, 2003, 22 (02) :121-128

← 1 2 →